Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
10.1007/s11427-023-2549-2 79
Gut 69 (8), 14231431
The primary risk is therapeutic failure if your blood glucose levels are not adequately controlled due to reduced medication potency, you may experience hyperglycemia
In SRM mode, the unique tryptic peptides of IGF-1 and LR3 are monitored using a TSQ Vantage, with the resulting area of the IGF-1 peptide used to quantify the IGF-1 after its normalization to the area of the LR3 peptide
US$ 22.60
US$ 29.78
US$ 25.53
US$ 27.58
US$ 21.19
